EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Aspects in Subacute Thyroiditis: A Real-Life Study on 226 Cases in Greece Amid the COVID-19 Pandemic

Nikolaos Angelopoulos iD, Dimitrios P Askitis iD, Ioannis Androulakis, Nicolas Valvis, Rodis Paparodis iD, Valentina Petkova, Anastasios Boniakos iD, Dimitra Zianni, Ilias Perogamvros, Konstantinos Toulis, Sarantis Livadas, Ioannis Iakovou

Journal of Clinical Medicine · 18.11.2023 · 12 (22) · 7171

DOI: 10.3390/jcm12227171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 18.11.2023. Verfasst von Nikolaos Angelopoulos und 11 weiteren Autor:innen. Beteiligte Einrichtung: Academic Department of Nuclear Medicine, School of Medicine, AHEPA University Hospital, 54636 Thessaloniki, Greece. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to evaluate various therapeutic approaches, identify potential predictive factors for the recurrence and development of hypothyroidism, and examine specific clinical and laboratory characteristics of patients with subacute thyroiditis (SAT) due to SARS-CoV-2 infection.

Methods

We retrospectively analyzed the medical records of 226 patients with confirmed SAT diagnosed from January 2020 to November 2022.

Results

The mean age was 48.01 ± 0.75 years, and the F/M ratio was 2.3/1. At the end of the follow-up period, 69 patients (32.1%) had developed hypothyroidism. Treatment duration was significantly shorter with nonsteroidal anti-inflammatory drugs (NSAIDs) (17.40 ± 2.56 days), while time-to-symptom relief was shorter with glucocorticoids (CGs). Recurrence was observed only in those treated with corticosteroid preparations (14.1%). C-reactive protein levels at treatment discontinuation were higher in patients who experienced SAT recurrence, while the coexistence of Hashimoto’s thyroiditis was a significant predictive factor for the development of hypothyroidism. The TSH value at the time of treatment withdrawal >4.12 μIU/mL showed optimal sensitivity and specificity for the prediction of permanent hypothyroidism. Regarding COVID-19, 34 patients (15%) experienced related SAT, with similar clinical manifestations of the disease but a higher BMI and shorter time-to-symptom relief.

Conclusion

In conclusion, GCs administration alleviated acute symptoms earlier during the onset of SAT, whereas NSAIDs had a shorter treatment duration, and both regimens could not prevent the development of delayed hypothyroidism. The clinical characteristics of SAT due to COVID-19 infections were similar to those of typical SAT disease.

Schlagwörter

Stichwörter der Autor:innen

SARS-CoV-2 complicationshypothyroidismnatural historyrecurrencessubacute thyroiditis (SAT)

Autor:innen und Institutionen

  • Academic Department of Nuclear Medicine, School of Medicine, AHEPA University Hospital, 54636 Thessaloniki, Greece.
  • Athens Medical Centre, 65403 Athens, Greece.
  • Center for Diabetes and Endocrine Research, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43606, USA.
  • Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, University of Manchester, Manchester M13 9PL, UK.
  • Diabetes Unit, Division of Endocrinology, 1st Department of Internal Medicine, AHEPA University Hospital, 54636 Thessaloniki, Greece.

ORCID-Profile: Nikolaos Angelopoulos, Dimitrios P Askitis, Rodis Paparodis, Anastasios Boniakos

Zitieren

APA

Angelopoulos, N., Askitis, D. P., Androulakis, I., Valvis, N., Paparodis, R., Petkova, V., Boniakos, A., Zianni, D., Perogamvros, I., Toulis, K., Livadas, S., & Iakovou, I. (2023). Clinical Aspects in Subacute Thyroiditis: A Real-Life Study on 226 Cases in Greece Amid the COVID-19 Pandemic. Journal of Clinical Medicine, 12(22), 7171. https://doi.org/10.3390/jcm12227171

Vancouver

Angelopoulos N, Askitis DP, Androulakis I, Valvis N, Paparodis R, Petkova V, et al. Clinical Aspects in Subacute Thyroiditis: A Real-Life Study on 226 Cases in Greece Amid the COVID-19 Pandemic. Journal of Clinical Medicine. 2023;12(22):7171. doi:10.3390/jcm12227171

BibTeX
@article{Angelopoulos2023,
  author = {Angelopoulos, Nikolaos and Askitis, Dimitrios P and Androulakis, Ioannis and Valvis, Nicolas and Paparodis, Rodis and Petkova, Valentina and Boniakos, Anastasios and Zianni, Dimitra and Perogamvros, Ilias and Toulis, Konstantinos and Livadas, Sarantis and Iakovou, Ioannis},
  title = {Clinical Aspects in Subacute Thyroiditis: A Real-Life Study on 226 Cases in Greece Amid the COVID-19 Pandemic},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {22},
  pages = {7171},
  doi = {10.3390/jcm12227171}
}
Kostenlos starten →